This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
CORRELATION OF IMMUNOHISTOCHEMICAL EXPRESSION OF BETA-CATENIN AND C-MYC WITH AGGRESSIVITY IN GASTRIC TUMORS / CORRELAÇÃO DA EXPRESSÃO IMUNOISTOQUíMICA DE BETA-CATENINA E C-MYC COM A AGRESSIVIDADE EM TUMORES DO ESTÔMAGO
Preprint
in Portuguese
| SciELO Preprints
| ID: pps-4139
Responsible library:
BR1.1
ABSTRACT
Background:
Biomarkers are macromolecules present in the body that may be related to neoplastic cells. None of them for diagnosis for secondary prevention were defined for gastric cancer.Objective:
To investigate the immunohistochemical expression of beta-catenin and c-MYC proteins in gastric cancer and to correlate them with the aggressiveness of gastric tumors.Method:
The sample consisted of histopathological slides, stained by H&E and paraffin blocks, and immunostained. Retrospective clinical data were collected. Clinical and epidemiological information was cross-referenced with the result obtained by immunostaining and its statistical analysis.Results:
There was a predominance of men (69.1%), with a mean age of 63.8 years, with a predominance of lesions located in the antrum (54.5%), poorly differentiated (49.1%) with signet ring cells in 30 % of cases. On average, 18 lymph nodes were resected and in 30% no affected lymph nodes were detected. In 42.7% there was already distant metastasis, predominantly liver (61.7%). Stage IV was the classification of 43.6%, not being detected angiolymphatic invasion in 77.3% and perineural in 65.5%. Treatment was surgical and chemotherapy in 87.3%, with R0 resection in 79.1%. c-MYC was negative in 99.1% and beta-catenin was not expressed in 90.9%, being inconclusive in 6 cases.Conclusion:
The immunohistochemical expression of these proteins in tissues with gastric cancer was not observed. The analyzed biomarkers, c-MYC and beta-catenin, showed no association with tumor aggressiveness in this cancerRESUMO
Racional Biomarcadores são macromoléculas presentes no organismo que podem estar relacionadas com células neoplásicas. Nenhum deles para diagnóstico para prevenção secundária foi definido para o câncer gástrico. Objetivo:
Investigar a expressão imunoistoquímica das proteínas beta-catenina e c-MYC no câncer gástrico e correlacioná-las com a agressividade dos tumores do estômago.Método:
A amostra consistiu em lâminas histopatológicas, coradas por H&E e blocos de parafina, e realizada imunomarcação. Dados clínicos retrospectivos foram coletados. As informações clinicoepidemiológicas foram cruzadas com o resultado obtido pela imunomarcação e sua análise estatística.Resultado:
Houve predomínio de homens (69,1%), com idade média de 63,8 anos, predominando lesão localizada
Full text:
Available
Collection:
Preprints
Database:
SciELO Preprints
Language:
Portuguese
Year:
2022
Document type:
Preprint